Produktname:(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid
IUPAC Name:2-(2-{2-[2-(2-{2-[(4S)-5-(tert-butoxy)-4-[20-(tert-butoxy)-20-oxoicosanamido]-5-oxopentanamido]ethoxy}ethoxy)acetamido]ethoxy}ethoxy)acetic acid
- CAS:1188328-37-1
- Molekulare Formel:C45H83N3O13
- Reinheit:99% HPLC
- Katalognummer:CM1075330
- Molekulargewicht:874.17
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1188328-37-1
- Molekulare Formel:C45H83N3O13
- Schmelzpunkt:-
- SMILES-Code:CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(O)=O)C(=O)OC(C)(C)C
- Dichte:
- Katalognummer:CM1075330
- Molekulargewicht:874.17
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Fatty Acid Modified Side Chains
- Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.